SSTR2 and ovarian carcinoma: Our previous study in vitro using the human ovarian cancer cell line found that paclitaxel-resistant cancer cells express high levels of SSTR2, and POC treatment could lead to more cell apoptosis when compared to cells treated with paclitaxel alone.